01 10Gowling WLG (Canada) LLP
Patent Expiration Date : 1937-09-22
Date Granted : 2025-05-06
Brand Name : EBGLYSS
Patent Number : 3031589
Filing Date : 2017-09-22
Strength per Unit : 250mg / 2mL (Prefilled Pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1937-09-22
Date Granted : 2025-05-06
Patent Expiration Date : 1937-09-22
Date Granted : 2025-05-06
Brand Name : EBGLYSS
Patent Number : 3031589
Filing Date : 2017-09-22
Strength per Unit : 250mg / 2mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1937-09-22
Date Granted : 2025-05-06
Patent Expiration Date : 2024-12-23
Date Granted : 2018-01-23
Brand Name : EBGLYSS
Patent Number : 2550651
Filing Date : 2004-12-23
Strength per Unit : 250mg / 2mL (Prefilled Pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-12-23
Date Granted : 2018-01-23
Patent Expiration Date : 1932-10-30
Date Granted : 2020-07-14
Brand Name : EBGLYSS
Patent Number : 2849210
Filing Date : 2012-10-30
Strength per Unit : 250mg / 2mL (Prefilled Pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1932-10-30
Date Granted : 2020-07-14
Patent Expiration Date : 1932-10-30
Date Granted : 2022-10-11
Brand Name : EBGLYSS
Patent Number : 3078979
Filing Date : 2012-10-30
Strength per Unit : 250mg / 2mL (Prefilled Pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1932-10-30
Date Granted : 2022-10-11
Patent Expiration Date : 1934-09-12
Date Granted : 2023-03-21
Brand Name : EBGLYSS
Patent Number : 2921999
Filing Date : 2014-09-12
Strength per Unit : 250mg / 2mL (Prefilled Pen)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1934-09-12
Date Granted : 2023-03-21
Patent Expiration Date : 2024-12-23
Date Granted : 2018-01-23
Brand Name : EBGLYSS
Patent Number : 2550651
Filing Date : 2004-12-23
Strength per Unit : 250mg / 2mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2024-12-23
Date Granted : 2018-01-23
Patent Expiration Date : 1932-10-30
Date Granted : 2020-07-14
Brand Name : EBGLYSS
Patent Number : 2849210
Filing Date : 2012-10-30
Strength per Unit : 250mg / 2mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1932-10-30
Date Granted : 2020-07-14
Patent Expiration Date : 1932-10-30
Date Granted : 2022-10-11
Brand Name : EBGLYSS
Patent Number : 3078979
Filing Date : 2012-10-30
Strength per Unit : 250mg / 2mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1932-10-30
Date Granted : 2022-10-11
Patent Expiration Date : 1934-09-12
Date Granted : 2023-03-21
Brand Name : EBGLYSS
Patent Number : 2921999
Filing Date : 2014-09-12
Strength per Unit : 250mg / 2mL (prefilled syringe)
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 1934-09-12
Date Granted : 2023-03-21
